The company holds the #1 rank in prescriptions over the last 8 years. Several of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, Prega News in pregnancy test kits, and Unwanted-72 in emergency contraception. Beyond pharmaceuticals, the company engages in trading and exporting of healthcare products, manufacture of packing materials and ayurvedic products, and offers products under 20+ recognized brand names.
Cyborg Score Rationale
Q3 FY26 revenue grew 11.5% YoY to ₹3,567 Cr with adjusted EBITDA margin of 25.9%, reflecting solid operational performance. The company benefits from market leadership in prescriptions and strong consumer healthcare brands, though recent regulatory scrutiny warrants monitoring.
Top Insights
Market leader with #1 ranking in prescription growth for 8+ consecutive years